Map the competitive landscape using public-domain intelligence. Track competitor regulatory filings, clinical trial signals, pricing announcements, and HTA decisions — aggregated and analysed before your rivals act on them.
Public signals are already out there. The question is whether your team sees them first.
CrossIntell Public transforms fragmented public data into a coherent competitive picture — continuously updated so your strategy is never built on stale assumptions.
Build a living map of the competitive environment across therapeutic areas and geographies. Track pipeline entrants, approval timelines, pricing benchmarks, and access positioning for every relevant competitor.
Aggregate and parse public filings from FDA, EMA, PMDA, and 40+ additional regulatory bodies. Surface competitor submissions, label expansions, and approval patterns as they emerge.
Monitor ClinicalTrials.gov, EudraCT, and patent filings for early-stage competitor signals. Identify pipeline entrants 18–36 months before they reach commercial launch — with time to respond.
Compare your pricing position and access coverage against public benchmarks across markets. Identify where competitors hold structural advantages and where white space remains uncontested.
Equip your strategy and market access teams with a competitive intelligence feed that never sleeps and never misses a filing.
Request Early Access